Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 3082805, 13 pages
https://doi.org/10.1155/2017/3082805
Research Article

Indirubin Treatment of Lipopolysaccharide-Induced Mastitis in a Mouse Model and Activity in Mouse Mammary Epithelial Cells

1The Faculty of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
2The Faculty of Animal Sciences and Technology, Huazhong Agricultural University, Wuhan 430070, China
3State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, China

Correspondence should be addressed to Chang-min Hu; nc.ude.uazh.liam@mch

Received 6 September 2016; Revised 13 December 2016; Accepted 27 December 2016; Published 1 February 2017

Academic Editor: Vinod K. Mishra

Copyright © 2017 Jin-lun Lai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Y. Miller, P. C. Bartlett, S. E. Lance, J. Anderson, and L. E. Heider, “Costs of clinical mastitis and mastitis prevention in dairy herds,” Journal of the American Veterinary Medical Association, vol. 202, no. 8, pp. 1230–1236, 1993. View at Google Scholar · View at Scopus
  2. T. Halasa, K. Huijps, O. Østerås, and H. Hogeveen, “Economic effects of bovine mastitis and mastitis management: a review,” The Veterinary Quarterly, vol. 29, no. 1, pp. 18–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Fonseca, P. V. Silva, C. C. Lange et al., “Expression profile of genes associated with mastitis in dairy cattle,” Genetics and Molecular Biology, vol. 32, no. 4, pp. 776–781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. De Vliegher, L. K. Fox, S. Piepers, S. McDougall, and H. W. Barkema, “Invited review: mastitis in dairy heifers. Nature of the disease, potential impact, prevention, and control,” Journal of Dairy Science, vol. 95, no. 3, pp. 1025–1040, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Watts, “Etiological agents of bovine mastitis,” Veterinary Microbiology, vol. 16, no. 1, pp. 41–66, 1988. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Konsman, P. Parnet, and R. Dantzer, “Cytokine-induced sickness behaviour: mechanisms and implications,” Trends in Neurosciences, vol. 25, no. 3, pp. 154–159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Anon, Veterinary Investigation Surveillance Report, Veterinary Laboratories Agency, London, UK, 2001.
  8. D. L. Granger, J. B. Hibbs Jr., and L. M. Broadnax, “Urinary nitrate excretion in relation to murine macrophage activation,” The Journal of Immunology, vol. 146, no. 4, pp. 1294–1302, 1991. View at Google Scholar · View at Scopus
  9. J. Hirvonen, K. Eklund, A. M. Teppo et al., “Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis,” Acta Veterinaria Scandinavica, vol. 40, no. 1, pp. 35–46, 1999. View at Google Scholar · View at Scopus
  10. F. Vangroenweghe, P. Rainard, M. Paape, L. Duchateau, and C. Burvenich, “Increase of Escherichia coli inoculum doses induces faster innate immune response in primiparous cows,” Journal of Dairy Science, vol. 87, no. 12, pp. 4132–4144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Alexander and E. T. Rietschel, “Invited review. Bacterial lipopolysaccharides and innate immunity,” Journal of Endotoxin Research, vol. 7, no. 3, pp. 167–202, 2001. View at Google Scholar
  12. K. Hoebe, X. Du, P. Georgel et al., “Identification of Lps2 as a key transducer of MyD88-independent TIR signalling,” Nature, vol. 424, no. 6950, pp. 743–748, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. W. Covert, T. H. Leung, J. E. Gaston, and D. Baltimore, “Achieving stability of lipopolysaccharide-induced NF-κB activation,” Science, vol. 309, no. 5742, pp. 1854–1857, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. I. Miller, R. K. Ernst, and M. W. Bader, “LPS, TLR4 and infectious disease diversity,” Nature Reviews Microbiology, vol. 3, no. 1, pp. 36–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. B. E. Gillespie, H. Moorehead, P. Lunn et al., “Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows,” Veterinary Therapeutics : Research in Applied Veterinary Medicine, vol. 3, no. 4, pp. 373–380, 2002. View at Google Scholar · View at Scopus
  16. D. Ferber, “Antibiotic resistance. Livestock feed ban preserves drugs' power,” Science, vol. 295, no. 5552, pp. 27–28, 2002. View at Google Scholar · View at Scopus
  17. Z. Xiao, Y. Hao, B. Liu, and L. Qian, “Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China,” Leukemia and Lymphoma, vol. 43, no. 9, pp. 1763–1768, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Kunikata, T. Tatefuji, H. Aga, K. Iwaki, M. Ikeda, and M. Kurimoto, “Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity,” European Journal of Pharmacology, vol. 410, no. 1, pp. 93–100, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Z. Ma and B. Y. Yao, “Progress in indirubin treatment of chronic myelocytic leukemia,” Journal of Traditional Chinese Medicine, vol. 3, no. 3, pp. 245–248, 1983. View at Google Scholar · View at Scopus
  20. T. Blažević, E. H. Heiss, A. G. Atanasov, J. M. Breuss, V. M. Dirsch, and P. Uhrin, “Indirubin and indirubin derivatives for counteracting proliferative diseases,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 654098, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-K. Kim, E. K. Shin, Y.-H. Kang, and J. H. Y. Park, “Indirubin-3′-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis,” Journal of Cellular Biochemistry, vol. 112, no. 5, pp. 1384–1391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Ravichandran, A. Pal, and R. Ravichandran, “Effect of indirubin-3-monoxime against lung cancer as evaluated by histological and transmission electron microscopic studies,” Microscopy Research and Technique, vol. 73, no. 11, pp. 1053–1058, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. F. G. E. Perabo, G. Landwehrs, C. Frössler, D. H. Schmidt, and S. C. Mueller, “Antiproliferative and apoptosis inducing effects of indirubin-3′-monoxime in renal cell cancer cells,” Urologic Oncology: Seminars and Original Investigations, vol. 29, no. 6, pp. 815–820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. T. Varela, A. M. Simões, J. S. Teodoro et al., “Indirubin-3′-oxime prevents hepatic I/R damage by inhibiting GSK-3β and mitochondrial permeability transition,” Mitochondrion, vol. 10, no. 5, pp. 456–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Polychronopoulos, P. Magiatis, A.-L. Skaltsounis et al., “Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases,” Journal of Medicinal Chemistry, vol. 47, no. 4, pp. 935–946, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-A. Kim, S.-M. Kwon, J.-A. Kim, K. W. Kang, J.-H. Yoon, and S.-G. Ahn, “5′-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of integrin β1/FAK/Akt signaling,” Cancer Letters, vol. 306, no. 2, pp. 197–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M.-J. Lee, M.-Y. Kim, J.-S. Mo et al., “Indirubin-3′-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling,” Cancer Letters, vol. 265, no. 2, pp. 215–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Engel, C. A. Kellermann, G. Burnat, E. G. Hahn, T. Rau, and P. C. Konturek, “Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis,” Journal of Physiology and Pharmacology, vol. 61, no. 1, pp. 89–97, 2010. View at Google Scholar · View at Scopus
  29. J. Schmidt, D. W. Rattner, K. Lewandrowski et al., “A better model of acute pancreatitis for evaluating therapy,” Annals of Surgery, vol. 215, no. 1, pp. 44–56, 1992. View at Publisher · View at Google Scholar · View at Scopus
  30. M. M. Ip, P. A. Masso-Welch, S. F. Shoemaker, W. K. Shea-Eaton, and C. Ip, “Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture,” Experimental Cell Research, vol. 250, no. 1, pp. 22–34, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Angius and A. Floris, “Liposomes and MTT cell viability assay: an incompatible affair,” Toxicology in Vitro, vol. 29, no. 2, pp. 314–319, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-T. Chen, J.-Y. Li, Y. Zhang, X. Gao, and H. Cai, “Recombinant MPT83 derived from Mycobacterium tuberculosis induces cytokine production and upregulates the function of mouse macrophages through TLR2,” The Journal of Immunology, vol. 188, no. 2, pp. 668–677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. Zhang, Y. Yang, S. Yan et al., “A novel pro-inflammatory protein of Streptococcus suis 2 induces the Toll-like receptor 2-dependent expression of pro-inflammatory cytokines in RAW 264.7 macrophages via activation of ERK1/2 pathway,” Frontiers in Microbiology, vol. 6, article 178, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Wang, M. Guo, X. Song et al., “Stevioside plays an anti-inflammatory role by regulating the NF-κB and MAPK pathways in S. aureus-infected mouse mammary glands,” Inflammation, vol. 37, no. 5, pp. 1837–1846, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Zheng, Y. Xu, J. Lu et al., “Variant innate immune responses of mammary epithelial cells to challenge by Staphylococcus aureus, Escherichia coli and the regulating effect of taurine on these bioprocesses,” Free Radical Biology and Medicine, vol. 96, pp. 166–180, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Li, N. Zhang, Y. Cao et al., “Emodin ameliorates lipopolysaccharide-induced mastitis in mice by inhibiting activation of NF-κB and MAPKs signal pathways,” European Journal of Pharmacology, vol. 705, no. 1–3, pp. 79–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. J. W. Blum, H. Dosogne, D. Hoeben et al., “Tumor necrosis factor-α and nitrite/nitrate responses during acute mastitis induced by Escherichia coli infection and endotoxin in dairy cows,” Domestic Animal Endocrinology, vol. 19, no. 4, pp. 223–235, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. K.-K. Park, J.-H. Park, Y.-J. Jung, and W.-Y. Chung, “Inhibitory effects of chlorophyllin, hemin and tetrakis(4-benzoic acid)porphyrin on oxidative DNA damage and mouse skin inflammation induced by 12-O-tetradecanoylphorbol-13-acetate as a possible anti-tumor promoting mechanism,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 542, no. 1-2, pp. 89–97, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Zhang and J. An, “Cytokines, inflammation, and pain,” International Anesthesiology Clinics, vol. 45, no. 2, pp. 27–37, 2007. View at Publisher · View at Google Scholar
  40. M. Paape, J. Mehrzad, X. Zhao, J. Detilleux, and C. Burvenich, “Defense of the bovine mammary gland by polymorphonuclear neutrophil leukocytes,” Journal of Mammary Gland Biology and Neoplasia, vol. 7, no. 2, pp. 109–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Arditi, J. Zhou, R. Dorio et al., “Endotoxin-mediated endothelial cell injury and activation. Role of soluble CD14,” Infection and Immunity, vol. 61, no. 8, pp. 3149–3156, 1993. View at Google Scholar
  42. E. J. Sohn, The interrelationship between CD14 and LPS during mastitis. release of soluble CD14 and cytokines by bovine PMN following activationwith LPS, University of Maryland, 2005.
  43. P. Rainard and C. Riollet, “Innate immunity of the bovine mammary gland,” Veterinary Research, vol. 37, no. 3, pp. 369–400, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Sweitzer, R. W. Colburn, M. Rutkowski, and J. A. Deleo, “Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat,” Brain Research, vol. 829, no. 1-2, pp. 209–221, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. J. W. Christman, R. T. Sadikot, and T. S. Blackwell, “The role of nuclear factor-κ B in pulmonary diseases,” Chest, vol. 117, no. 5, pp. 1482–1487, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. M. K. Connolly, A. S. Bedrosian, J. M.-S. Clair et al., “In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-α,” Journal of Clinical Investigation, vol. 119, no. 11, pp. 3213–3225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Akira, K. Takeda, and T. Kaisho, “Toll-like receptors: critical proteins linking innate and acquired immunity,” Nature Immunology, vol. 2, no. 8, pp. 675–680, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Beutler, K. Hoebe, X. Du, and R. J. Ulevitch, “How we detect microbes and respond to them: the Toll-like receptors and their transducers,” Journal of Leukocyte Biology, vol. 74, no. 4, pp. 479–485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. H. K. Lee and A. Iwasaki, “Innate control of adaptive immunity: dendritic cells and beyond,” Seminars in Immunology, vol. 19, no. 1, pp. 48–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Boulanger, L. Bouchard, X. Zhao, and P. Lacasse, “Induction of nitric oxide production by bovine mammary epithelial cells and blood leukocytes,” Journal of Dairy Science, vol. 84, no. 6, pp. 1430–1437, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Trakranrungsie and J. Will, “Expression of iNOS and COX-2 proteins during endotoxin-induced mastitis in guinea pigs,” FASEB Journal, vol. 11, no. 3, pp. 1829–1829, 1997. View at Google Scholar
  53. C.-C. Chen, Y.-T. Sun, J.-J. Chen, and Y.-J. Chang, “Tumor necrosis factor α-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IκB kinase 1/2 in human alveolar epithelial cells,” Molecular Pharmacology, vol. 59, no. 3, pp. 493–500, 2001. View at Google Scholar · View at Scopus
  54. Y.-C. Oh, W.-K. Cho, Y. H. Jeong et al., “A novel herbal medicine KIOM-MA exerts an anti-inflammatory effect in LPS-stimulated RAW 264.7 macrophage cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 462383, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. S. Hayden and S. Ghosh, “NF-κB, the first quarter-century: remarkable progress and outstanding questions,” Genes and Development, vol. 26, no. 3, pp. 203–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Vallabhapurapu and M. Karin, “Regulation and function of NF-κB transcription factors in the immune system,” Annual Review of Immunology, vol. 27, pp. 693–733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. W. Wei, L. Dejie, S. Xiaojing et al., “Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model,” Inflammation, vol. 38, no. 1, pp. 16–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. Z. Yang, R. Yin, Y. Cong et al., “Oxymatrine lightened the inflammatory response of LPS-induced mastitis in mice through affecting NF-κB and MAPKs signaling pathways,” Inflammation, vol. 37, no. 6, pp. 2047–2055, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Li, D. Liang, Z. Yang et al., “Astragalin suppresses inflammatory responses via down-regulation of NF-κB signaling pathway in lipopolysaccharide-induced mastitis in a murine model,” International Immunopharmacology, vol. 17, no. 2, pp. 478–482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. J.-K. Kim and G.-M. Park, “ndirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells,” Inflammation Research, vol. 61, no. 4, pp. 319–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Kaminska, “MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits,” Biochimica et Biophysica Acta (BBA)—Proteins and Proteomics, vol. 1754, no. 1-2, pp. 253–262, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Seger and E. G. Krebs, “The MAPK signaling cascade,” FASEB Journal, vol. 9, no. 9, pp. 726–735, 1995. View at Google Scholar · View at Scopus